Heparin Administration After Thrombolysis When Revascularization is Not Planned
After thrombolysis, unfractionated heparin (UFH) should be initiated immediately when the activated partial thromboplastin time (aPTT) has decreased to less than twice the normal control value, without a loading dose, and continued for 24-48 hours. 1
Timing and Dosing of Heparin Post-Thrombolysis
Initial Administration
- Begin UFH without a loading dose when aPTT decreases to less than twice normal control value (typically when aPTT < 80 seconds) 1
- Initial dosage is typically 1,300 U/h (approximately 20,000-40,000 U/24h) 1, 2
- Target aPTT of 1.5-2.0 times normal control (approximately 55-80 seconds) 1, 2
Monitoring Protocol
- Check aPTT four times every 6 hours initially, then three times every 8 hours, then daily 1
- Continue UFH for 24-48 hours after thrombolysis when revascularization is not planned 1
- For ST-elevation myocardial infarction (STEMI), continue UFH for up to 48 hours or until revascularization 1
Duration of Therapy Based on Clinical Scenario
For STEMI without planned revascularization:
For ischemic stroke:
For prosthetic valve thrombosis:
Transitioning to Oral Anticoagulation
- Begin oral anticoagulant (warfarin) simultaneously with heparin 1
- Continue heparin until INR reaches therapeutic range (typically 2.0-3.0) for at least 2 consecutive days 1, 2
- For venous thromboembolism, overlap heparin with warfarin for at least 4-5 days 2
Potential Complications and Management
Bleeding Complications
- If major bleeding occurs, immediately terminate heparin infusion 1
- For severe bleeding, consider reversal with fresh-frozen plasma or prothrombin complex concentrate 1
Monitoring for Complications
- Monitor hemoglobin/hematocrit daily 2
- Check platelet count daily to detect heparin-induced thrombocytopenia (HIT) 2
Special Considerations
- In patients with cerebral embolism during thrombolysis, discontinue thrombolytic treatment immediately and obtain urgent CT scan 1
- If stroke is non-hemorrhagic, anticoagulation may be resumed after 24-48 hours 1
- For patients with heparin resistance, consider switching to anti-Xa monitoring with target range of 0.35-0.7 units/mL 2
Common Pitfalls to Avoid
Avoid simultaneous anticoagulant therapy during thrombolysis - During thrombolytic treatment, adjuvant anticoagulant therapy is not recommended 1
Avoid loading dose after thrombolysis - Begin heparin without a loading dose when aPTT decreases to less than twice normal 1
Avoid inadequate monitoring - Failure to achieve adequate anticoagulation is associated with high risk of recurrent thromboembolism 3
Avoid switching between UFH and LMWH - Switching from UFH to LMWH and vice versa should generally be avoided 1
By following these guidelines, clinicians can optimize the timing and dosing of heparin therapy after thrombolysis when revascularization is not planned, balancing the need for effective anticoagulation with minimizing bleeding risk.